S. 526-1079-1113: Brevettabilità dei medicamenti

This procedure concerns the patentability of medicinal products. It aims to clarify the rules and conditions under which medicines can be patented, ensuring a balance between innovation incentives and public access to healthcare. The outcome of this procedure could affect pharmaceutical companies, researchers, and patients by influencing the availability and cost of medicines. It addresses legal and ethical considerations in drug development.